Corrigendum: Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma

• Daniel Benitez-Ribas,
• Raquel Cabezón,
• Georgina Flórez-Grau,
• Mari Carmen Molero,
• Patricia Puerta,
• Antonio Guillen,
• E. Azucena González-Navarro,
• Sonia Paco,
• Sonia Paco,
• Angel M. Carcaboso,
• Angel M. Carcaboso,
• Vicente Santa-Maria Lopez,
• Vicente Santa-Maria Lopez,
• Ofelia Cruz,
• Ofelia Cruz,
• Carmen de Torres,
• Carmen de Torres,
• Noelia Salvador,
• Noelia Salvador,
• Manel Juan,
• Manel Juan,
• Jaume Mora,
• Jaume Mora,
• Andres Morales La Madrid,
• Andres Morales La Madrid,
• Andres Morales La Madrid

Affiliations

Daniel Benitez-Ribas

Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain

Raquel Cabezón

Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain

Georgina Flórez-Grau

Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain

Mari Carmen Molero

Department of Clinical Trials, Hospital Sant Joan de Déu, Barcelona, Spain

Patricia Puerta

Department of Neurosurgery, Hospital Sant Joan de Déu, Barcelona, Spain

Antonio Guillen

Department of Neurosurgery, Hospital Sant Joan de Déu, Barcelona, Spain

E. Azucena González-Navarro

Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain

Sonia Paco

Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain

Sonia Paco

Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain

Angel M. Carcaboso

Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain

Angel M. Carcaboso

Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain

Vicente Santa-Maria Lopez

Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain

Vicente Santa-Maria Lopez

Department of Neuro-Oncology, Hospital Sant Joan de Déu, Barcelona, Spain

Ofelia Cruz

Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain

Ofelia Cruz

Department of Neuro-Oncology, Hospital Sant Joan de Déu, Barcelona, Spain

Carmen de Torres

Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain

Carmen de Torres

Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain

Noelia Salvador

Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain

Noelia Salvador

Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain

Manel Juan

Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain

Manel Juan

Department of Immunotherapy, Hospital Sant Joan de Déu, Barcelona, Spain

Jaume Mora

Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain

Jaume Mora

Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain

Andres Morales La Madrid

Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain

Andres Morales La Madrid

Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain

Andres Morales La Madrid

Department of Neuro-Oncology, Hospital Sant Joan de Déu, Barcelona, Spain